GENinCode (LON:GENI) Shares Down 9.9% – Time to Sell?

GENinCode Plc (LON:GENIGet Free Report) was down 9.9% on Wednesday . The stock traded as low as GBX 3.10 ($0.04) and last traded at GBX 3.20 ($0.04). Approximately 915,767 shares changed hands during mid-day trading, an increase of 24% from the average daily volume of 736,967 shares. The stock had previously closed at GBX 3.55 ($0.05).

GENinCode Trading Down 9.9 %

The company has a debt-to-equity ratio of 9.28, a current ratio of 2.60 and a quick ratio of 15.89. The company’s 50 day moving average is GBX 3.72 and its two-hundred day moving average is GBX 4.42. The firm has a market cap of £5.67 million, a P/E ratio of -0.93 and a beta of 0.66.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Further Reading

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.